PR93678

SARATOGA SPRINGS, N.Y. and LONDON, Dec. 14, 2021 /PRNewswire=KYODO JBN/ --

The acquisition will bolster Fingerpaint's omnichannel offering, data and

analytics capabilities, and global presence.

Fingerpaint (

https://c212.net/c/link/?t=0&l=en&o=3388169-1&h=2971894065&u=https%3A%2F%2Fwww.fingerpaint.com%2F&a=Fingerpaint

), biopharma's global commercialization partner for analytics-enabled

integrated solutions, announced it acquired Engage (

https://c212.net/c/link/?t=0&l=en&o=3388169-1&h=224943795&u=https%3A%2F%2Fwww.engageagencies.com%2F%23site&a=Engage

), a London-based, award-winning, data and analytics–enabled healthcare

marketing firm. Details of the transaction were not disclosed.

Logo - https://mma.prnewswire.com/media/489237/Fingerpaint_Marketing_Logo.jpg  

Engage will expand Fingerpaint's European footprint and complement the

company's current data and analytics expertise.

"Strengthening our global infrastructure is reflective of the diversified

biopharma industry we serve worldwide," said Ed Mitzen, founder of Fingerpaint.

"Our combined global omnichannel marketing solutions guided by—and rooted

in—data will further Fingerpaint's position as a transformative digital partner

to biopharma's commercialization needs."

Mary McGregor and Dave Chandler, both founders and managing partners of Engage,

will continue to lead day-to-day operations.

"Integrating into Fingerpaint will allow us to leverage its award-winning

creative and digital talent and maximize omnichannel campaigns as we continue

to work with global brands at every stage of the commercialization process,"

said McGregor.

"Combining our expertise with Fingerpaint's will create best-in-class,

performance-based digital capabilities for clients across the company's

integrated firms," said Chandler.

Knox Lane, a private equity firm based in San Francisco, is a strategic

investor in Fingerpaint.

"Engage will help expand the data and analytics capabilities the industry has

come to expect from Fingerpaint, biopharma's leading commercialization

partner," said Shamik Patel, partner at Knox Lane.

Engage joins integrated Fingerpaint firms MedThink, a company that empowers

healthcare providers through medical communications; Leaderboard Branding, a

leading global naming and branding business; 1798, a market access and

commercialization firm that specializes in healthcare consulting services,

including patient and provider access services; and Photo 51, a consultancy

focused solely on advanced therapeutics, such as gene and cell therapies.

About Fingerpaint:

Independent by design and built on a foundation of empathy, Fingerpaint is

biopharma's global commercialization partner for analytics-enabled integrated

solutions. At its core is an award-winning global team of more than 700 people

who are committed to creating and executing meaningful brand experiences for

healthcare providers, care partners, and patients.

Fingerpaint was named 2021 Agency of the Year by Med Ad News, and in 2018, it

won the Heart Award from Med Ad News for its commitment to philanthropy and

social causes. Additionally, it has been on Inc. Magazine's list of the 5,000

Fastest-Growing Companies for the past eight years. Visit us at Fingerpaint.com

and follow us on Facebook, Twitter, LinkedIn, and Instagram.

About Engage:

Engage, a Fingerpaint company, is a London-based, award-winning, data and

analytics–enabled healthcare marketing firm. It delivers global omnichannel

marketing solutions powered by advanced data insights to deliver customer

engagement strategies, content and tech development, campaign deployment, and

real-time performance analysis.

Media Contact:

fingerpaint@jonesworks.com

SOURCE - Fingerpaint